VC-backed Entrada Therapeutics hires COO

Boston-based Entrada Therapeutics, a biotechnology company, has appointed Nathan J. Dowden as chief operating officer. Recently, he worked at Rubius Therapeutics where he was senior vice president of strategy and corporate development. Entrada's backers include 5AM Ventures, MPM Capital, Roche Venture Fund, MRL Ventures Fund and Agent Capital.

PeopleNorth AmericaUSHealthcareBriefs